100% of moneycontrol users recommend buying Piramal Enter.
What's your call on Piramal Enter today?
Read Investor view
|Company Name||Last Price||%
|Dr Reddys Labs||3200.60||-0.88||3353.85||2420.00||54,527.29|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
National Buildings Constr Recommended on Jul 14th 2014
Recommended price 396.00 | Peak from reco 767.50 93.69%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Piramal Enter is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 13,026.79 crore.The company has reported a consolidated sales of Rs 1,166.14 crore and a Net Profit of Rs 2,862.40 crore for the quarter ended Jun 2014.
The company management includes Ajay G Piramal - Chairman, Swati A Piramal - Vice Chairman, Nandini Piramal - Executive Director, Vijay Shah - Executive Director, Gautam Banerjee - Director, Amit Chandra - Director, Keki Dadiseth - Director, R A Mashelkar - Director, Goverdhan Mehta - Director, Siddharth Mehta - Director, S Ramadorai - Director, Deepak Satwalekar - Director, N Vaghul - Director.
It is listed on the BSE with a BSE Code of 500302 and the NSE with an NSE Code of PEL.
Its Registered office is at Piramal Tower, Ganpatrao Kadam Marg,,Lower Parel Mumbai,Maharashtra - 400013.
Their Registrars are Link Intime India Pvt. Ltd.